Previous population-based studies have reported an increased risk of cardiovascular disease (4, 12, 13), and a higher prevalence of chronic kidney disease (5) and metabolic dysfunction-associated steatotic liver disease (6) in patients with RIA compared with those with renin-dependent aldosteronism. This evidence concerns the gene REN and cardiovascular disorder.